Tag: Cancer: Laryngeal
Provider Volume Affects Outcome in IMRT for Head, Neck Cancer
Improved survival for patients treated by higher-volume radiation oncologists
Meta-Analysis Confirms miR-21 Expression, Laryngeal CA Link
High miR-21 expression seen in laryngeal cancer versus non-neoplasm tissue
Time to Tx Initiation Impacts Survival in Head, Neck Cancer
Lower overall survival for time to treatment initiation of more than 46 to 52 days
Suicide Risk Up for Head, Neck Cancer Patients
Dependence on breathing tubes, feeding tubes might play a part in despair
Loss of Heterozygosity Validated As Marker for Oral Cancer
EGFR inhibitor erlotinib doesn't improve cancer-free survival in high-risk LOH-positive patients
Neuromuscular Stimulation Doesn’t Aid Dysphagia Patients
Combining NMES with swallow exercises in head and neck cancer patients not helpful
High-Dose Hypofractionated RT Palliative in Head, Neck Cancer
Meaningful palliative effect for 63 percent of patients, lasting for median of 4.6 months
No Specific Findings to ID Recurrence in Head and Neck CA
No definite index of symptoms or signs indicating local recurrence, second primary malignancy
H. pylori Linked to Increased Odds of Laryngeal Carcinoma
Review shows significantly increased odds of laryngeal carcinoma but not pharyngeal cancer
Metformin Linked to Lower Risk of Head, Neck Cancer
Diabetes patients treated with the drug less likely to develop oropharyngeal, nasopharyngeal cancers
